Location History:
- Montpellier, FR (2005)
- Paris, FR (2012)
Company Filing History:
Years Active: 2005-2012
Title: Martine Vernhet: Innovator in Pharmaceutical Compounds
Introduction
Martine Vernhet is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents, her work focuses on therapeutic applications that have the potential to impact medical treatments.
Latest Patents
Martine's latest patents include groundbreaking inventions related to specific compounds. One of her notable inventions pertains to compounds corresponding to a defined formula, which are aimed at therapeutic uses. Another significant patent involves 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives, which serve as cannabinoid receptor antagonists. These tricyclic derivatives are designed to interact with cannabinoid CB receptors, and the patent details their preparation methods and pharmaceutical compositions.
Career Highlights
Martine Vernhet is currently associated with Sanofi-Aventis, a leading global healthcare company. Her role at the company allows her to leverage her expertise in pharmaceutical innovation and contribute to the development of new therapeutic solutions.
Collaborations
Throughout her career, Martine has collaborated with esteemed colleagues such as Francis Barth and Joseph Millan. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of impactful inventions.
Conclusion
Martine Vernhet's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a key innovator. Her work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in healthcare.